|
[1]
|
S. S. Mirvish, “Role of N-nitroso Compounds (NOC) and N-nitrosation in Etiology of Gastric, Esophageal, Nasopharyngeal and Bladder Cancer and Contribution to Cancer of Known Exposures to NOC,” Cancer Letters, Vol. 93, No. 1, 1995, pp. 17-48.
|
|
[2]
|
L. Cardenes, J. H. Ayala, V. González and A. M. Afonso, “Fast Microwave-Assisted Dansylation of N-nitrosamines Analysis by High-Performance Liquid Chromatography with Fluorescent Detection,” Journal of Chromatography, Vol. 946, No. 1-2, 2002, pp. 133-140.
|
|
[3]
|
I. T. Vermeer, E. J. Moonen, J. W. Dallinga, J. C. Kleinjans and J. M. van Maanen, “Effect of Ascorbic Acid and Green Tea on Endogenous Formation of N-nitrosodime- thylamine and N-nitrosopiperidine in Humans,” Mutation Research, Vol. 428, No. 1-2, 1999, pp. 353-361.
|
|
[4]
|
R. Andrade, F. G. R. Reyes and S. Rath, “A Method for the Determination of Volatile N-nitrosamines in Food by HS-SPME-GC-TEA,” Food Chemistry, Vol. 91, No. 1, 2005, pp. 173-179.
|
|
[5]
|
R. Gray, R. Peto, P. Brantom and P. Grasso, “Chronic Nitrosamine Ingestion in 1040 Rodents: The Effect of the Choice of Nitrosamine, The Species Studied, and the Age of Starting Exposure,” Cancer Research, Vol. 51, No. 23, 1991, pp. 6470-6491.
|
|
[6]
|
M. Greenblatt and W. Lijinsky, “Failure to Induce Tumors in Swiss Mice after Concurrent Administration of Amino Acids and Sodium Nitrite,” Journal of the National Cancer Institute, Vol. 48, No. 5, 1972, pp. 1389- 1392.
|
|
[7]
|
R. Preussmann and B. W. Stewart, “N-nitroso Carcinogens,” In: C. E. Searle, Ed., Chemical Carcinogens, American Chemical Society, Washington, D.C., 1984, pp. 643-828.
|
|
[8]
|
D. Y. Lai and J. C. Arcos, “Minireview: Dialkylnitrosamine Bioactivation and Carcinogenesis,” Life Sciences, Vol. 27, No. 23, 1980, pp. 2149-2165.
|
|
[9]
|
H. L. Wong, S. E. Murphy and S. S. Hecht, “Comparative Metabolism of N-nitrosopiperidine and N-nitrosopy- rrolidine by Rat Liver and Esophageal Microsomes and Cytochrome P450 2A3,” Carcinogenesis, Vol. 24, No. 2, 2003, pp. 291-300.
|
|
[10]
|
M. Leist, B. Single, A. F. Castoldi, S. Kuhnle and P. Nicotera, “Intracellular Adenosine Triphosphate (ATP) Concentration: A Switch in the Decision between Apoptosis and Necrosis,” Journal of Experimental Medicine, Vol. 185, No. 8, 1997, pp. 1481-1486.
|
|
[11]
|
A. H. Wyllie, J. F. R. Kerr and A. C. Currie, “Cell Death: The Significance of Apoptosis,” International Review of Cytology, Vol. 68, 1980, pp. 251-305.
|
|
[12]
|
S. H. Kaufmann and G. J. Gores, “Apoptosis in Cancer: Cause and Cure,” Bioessays, Vol. 22, No. 11, 2000, pp. 1007-1017.
|
|
[13]
|
L. Hegyi, S. J. Hardwick, R. C. M. Siow and J. N. Skepper, “Macrophage Death and the Role of Apoptosis in Human Atherosclerosis,” Journal of Hematotherapy & Stem Cell Research, Vol. 10, No. 1, 2001, pp. 27-42.
|
|
[14]
|
D. J. Granville, C. M. Carthy, H. Jiang, G. C. Shore, B. M. McManus and D. W. Hunt, “Rapid Cytochrome c Release, Activation of Caspases 3, 6, 7 and 8 followed by Bap31 Cleavage in HeLa Cells Treated with Photodynamic The- rapy,” FEBS Letters, Vol. 437, No. 1-2, 1998, pp. 5-10.
|
|
[15]
|
A. H. Wyllie, G. J. Beattie and A. D. Hargreaves, “Chromatin Changes in Apoptosis,” The Histochemical Journal, Vol. 13, No. 4, 1981, pp. 681-692.
|
|
[16]
|
D. L. Vaux, “Immunopathology of Apoptosis-Introduc- tion and Overview,” Semininars in Inmunopathology, Vol. 19, No. 3, 1998, pp. 271-278.
|
|
[17]
|
G. Kroemer, “Mitochondrial Implication in Apoptosis. Towards an Endosymbiotic Hypothesis of Apoptosis Evolution,” Cell Death and Differentiation, Vol. 4, No. 6, 1997, pp. 443-456.
|
|
[18]
|
A. Anel, S. Gamen, M. A. Alava, A. M. Schmitt-Verhulst, A. Pineiro and J. Naval, “ Inhibition of CPP32-Like Proteases Prevents Granzyme B- and Fas-, but not Granzyme A-Based Cytotoxicity Exerted by CTL Clones,” Immunology, Vol. 158, No. 5, 1997, pp. 1999-2006.
|
|
[19]
|
C. E. Schwab and H. Tuschl, “In vitro Studies on the Toxicity of Isoniazid in Different Cell Lines,” Human & Experimental Toxicology, Vol. 22, No. 11, 2003, pp. 607- 615.
|
|
[20]
|
V. M. Salas and S. W. Burchiel, “Apoptosis in Daudi Human B cells in Response to Benzo[a] pyrene and Benzo [a] pyrene-7,8-dihydrodiol,” Toxicology and Applied Pharmacology, Vol. 151, No. 2, 1998, pp. 367-376.
|
|
[21]
|
H. Ashida, K. Kihara, Y. Nonaka, I. Fukuda, B. Shiotani and T. Hashimoto, “The Heterocyclic Amine, 3-amino-1, 4-dimethyl-5H-pyrido[4,3-b]indole Induces Apoptosis in Cocultures of Rat Parenchymal and Nonparenchymal Liver Cells,” Toxicology and Applied Pharmacology, Vol. 177, No. 1, 2001, pp. 59-67.
|
|
[22]
|
T. Hashimoto, H. Ashida, T. Sano, T. Furuyashiki, Y. Hatanaka, K. Minato, M. Mizuno, K. Nomura, A. Kumatori, K. Kanazawa and G. Danno, “3-Amino-1,4-dimethyl -5H-pyrido[4,3-b]indole (Trp-P-1) Induces Caspase-De- pendent Apoptosis in Mononuclear Cells,” Biochimica et Biophysica Acta, Vol. 1539, No. 1-2, 2001, pp. 44-57.
|
|
[23]
|
S. H. Moon, H. W. Kim, J. S. Kim, J. H. Park, H. Kim, G. J. Eu, H. S. Cho, G. M. Kang, K. H. Lee and M. H. Cho, “Cap-Independent Protein Translation is Initially Res- ponsible for 4-(N-methylnitrosamino)-1-(3-pyridyl)-buta- none (NNK)-induced Apoptosis in Normal Human Bron- chial Epithelial Cells,” Journal of Veterinary Science, Vol. 5, No. 4, 2004, pp. 369-378.
|
|
[24]
|
J. A. Holme, M. Gorria, V. M. Arlt, S. Ovreb?, A. Solhaug, X. Tekpli, N. E. Landvik, L. Huc, O. Fardel and D. Lagadic-Gossmann, ”Different Mechanisms Involved in Apoptosis Following Exposure to Benzo[a]pyrene in F258 and Hepa1c1c7 Cells,” Chemico Biological Interactions, Vol. 167, No. 1, 2007, pp. 41-55.
|
|
[25]
|
J. Jablonski, E. Jablonska and M. Chojnowski, “The Influence of Very Low Doses of N-nitrosodimethylamine (NDMA) on the Apoptosis of Rat Neutrophils in vivo, the Role of Reactive Oxygen Species,” Toxicology, Vol. 165, No. 1, 2001, pp. 65-74.
|
|
[26]
|
H. L. Lin, L. A. Parsels, J. Maybaum and P. F. Hollenberg, “N-Nitrosodimethylamine-mediated Cytotoxicity in a Cell Line Expressing P450 2E1: Evidence for Apoptotic Cell Death,” Toxicology and Applied Pharmacology, Vol. 157, No. 2, 1999, pp.117-124.
|
|
[27]
|
H. Doostdar, M. H. Grant, W. T. Melvin, C. R. Wolf and M. D. Burke, “The Effects of Inducing Agents on Cytochrome P450 and UDP-glucuronyltransferase Activities in Human HEPG2 Hepatoma Cells,” Biochemical Pharmacology, Vol. 46, No. 4, 1993, pp. 629-635.
|
|
[28]
|
J. A. Holme, R. Wiger, J. K. Hongslo, E. Soderlund, G. Brunborg and E. Dybing, “Cell Death via Interactions of Agents with DNA,” Molecular and Cellular Biology, Vol. 20, 1997, pp. 145-182.
|
|
[29]
|
F. Nagai, Y. Hiyoshi, K. Sugimachi and H. Tamura, “Cytochrome P450 (CYP) Expression in Human Myeloblastic and Lymphoid Cell Lines,” Biological and Pharmaceutical Bulletin, Vol. 25, No. 3, 2002, pp. 383- 385.
|
|
[30]
|
J. B. Custodio, C. M. Cordoso and L. M. Almeida, “Thiol Protecting Agents and Antioxidants Inhibit the Mitochondrial Permeability Transition Promoted by Etoposide: Implications in the Prevention of Estoposide-Induced Apoptosis,” Chemico Biological Interactions, Vol. 140, 2002, pp. 169-184.
|
|
[31]
|
C. D. Gregory, C. Dive, S. Henderson, C. A. Smith and G. T. Williams, “Activation of Epstein-Barr Virus Latent Genes Protects Human B Cells from Death by Apoptosis,” Nature, Vol. 349, No. 6310, 1991, pp. 612-614.
|
|
[32]
|
K. U. Frohlich and F. Madeo, “Apoptosis in Yeast, a Monocelular Organism Exhibits Altruistic Behaviour,” FEBS Letters, Vol. 473, No. 1, 2000, pp. 6-9.
|
|
[33]
|
S. H. Kaufmann, S. Desnoyers, Y. Ottaviano, N. E. Davidson and G. G. Poirier, “Specific Proteolytic Cleavage of Poly-(Adpribose) Polymerase: An Early Marker of Chemotherapy Induced Apoptosis,” Cancer Research, Vol. 53, No. 17, 1999, pp. 3976-3985.
|
|
[34]
|
T. Rich, R. L. Allen and A. H. Wyllie, “Defying Death after DNA damage,” Nature, Vol. 407, No. 6805, 2000, pp. 777-783.
|
|
[35]
|
N. E. Landvik, M. Gorria, V. M. Arlt, N. Asare, A. Solhaug, D. Lagadic-Gossmann and J. A. Holme, “Effects of Nitrated-Polycyclic Aromatic Hydrocarbons and Diesel Exhaust Particle Extracts on Cell Signalling Related to Apoptosis: Possible Implications for their Mutagenic and Carcinogenic Effects,” Toxicology, Vol. 231, No. 2-3, 2007, pp. 159-174.
|
|
[36]
|
IARC, “Some N-nitroso Compounds,” In: IARC Monographs on the Evaluation of the Carcinogenic Risk of Chemical to Humans, International Agency for Research on Cancer, Lyon, 1978, p. 17.
|
|
[37]
|
M. Wang, Y. Lao, G. Cheng, Y. Shi, P. W. Villalta, A. Nishikawa and S. S. Hecht, “Analysis of Adducts in Hepatic DNA of Rats Treated with N-nitrosopyrrolidine,” Chemical Research in Toxicology, Vol. 20, No. 4, 2007, pp. 634-640.
|
|
[38]
|
G. Cheng, M. Wang, P. Upadhyaya, P. W. Villalta and S. S. Hecht, “Formation of Formaldehyde Adducts in the Reactions of DNA and Deoxyribonucleosides with Alpha- acetates of 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone (NNK), 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanol (NNAL) and N-nitrosodimethylamine (NDMA),” Chemi- cal Research in Toxicology, Vol. 21, No. 3, 2008, pp. 746-751.
|
|
[39]
|
W. P. Roos, M. Baumgartner and B. Kaina, “Apoptosis Triggered by DNA Damage O6-methylguanine in Human Lymhocytes Requires DNA Replication and is Mediated by p53 and Fas/CD95/Apo-1,” Oncogene, Vol. 23, No. 2, 2004, pp. 359-367.
|
|
[40]
|
G. Del Bino, Z. Darzynkiewicz, C. Degraef, R. Mosselmans, D. Fokan and P. Galand, “Comparison of Methods Based on Annexin-V Binding, DNA Content or TUNEL for Evaluating Cell Death in HL-60 and Adherent MCF-7 Cells,” Cell Proliferation, Vol. 32, No. 1, 1999, pp. 25- 37.
|
|
[41]
|
M. J. Gomez-Lechón, E. O’Connor, J. V. Castell and R. Jover, “Sensitive Markers Used to Identify Compounds That Trigger Apoptosis in Cultured Hepatocytes,” Toxicology Sciences, Vol. 65, No. 2, 2002, pp. 299-308.
|
|
[42]
|
T. Hashimoto, H. Ashida, T. Sano, T. Furuyashiki, B. Shiotani, K. Kanazawa and G. Danno, “3-Amino-1,4-di- methyl-5H-pyrido[4,3-b]indole (Trp-P-1) Induces Apoptosis in Rat Splenocytes and Thymocytes by Different Mechanisms,” Mutation Research, Vol. 457, No. 1-2, 2000, pp. 57-67.
|
|
[43]
|
R. Duc and P. M. Leong-Morgenthaller, “Heterocyclic Amine Induced Apoptotic Response in the Human Lymphoblastoid Cell Line TK6 is Linked to Mismatch Repair status,” Mutation Research, Vol. 486, No. 2, 2001, pp. 155-164.
|
|
[44]
|
A. García, P. Morales, N. Arranz, E. Delgado, J. Rafter, A. I. Haza, “Induction of Apoptosis and Reactive Oxygen Species Production by N-nitrosopiperidine and N-nitroso- dibutylamine in Human Leukemia Cells,” Journal of Applied Toxicology, Vol. 28, No. 4, 2007, pp. 455-465.
|
|
[45]
|
A. García, P. Morales, J. Rafter and A. I. Haza, “N-nitrosopi-peridine and N-nitrosodibutylamine Induce Apoptosis in Hepg2 Cells via the Caspase Dependent Pathway,” Cell Biology International, Vol. 33, No. 12, 2009, pp. 1280-1286.
|
|
[46]
|
K. I. Fujita and T. Kamataki, “Role of Human P450 (CYP) in the Metabolic Activation of N-alkylnitrosamines: Application of Genetically Engineered Salmonella Typhimurium YG7108 Expressing Each Form of CYP Together with Human NADPH-cytochrome P450 Reductase,” Mutation Research, Vol. 483, No. 1-2, 2001, pp. 35-41.
|
|
[47]
|
I. Valentin-Severin, L. Le Hegarat, J. C. Lhuguenot, A. M. Le Bon and M. C. Chagnon, “Use of Hep G2 Cell Line for Direct or Ondirect Mutagens Screening: Comparative Investigation between Comet and Micronucleus Assays,” Mutation Research, Vol. 536, No. 1-2, 2003, pp. 79-90.
|
|
[48]
|
B. J. Majer, V. Mersch-Sundermann, F. Darroudi, B. Laky, K. de Wit and S. Knasmüller, “Genotoxic Effects of Dietary and Lifestyle Related Carcinogens in Human Derived Hepatoma (HepG2, Hep3B) Cells,” Mutation Research, Vol. 551, No. 1-2, 2004, pp. 153-166.
|
|
[49]
|
N. Arranz, A. I. Haza, A. García, J. Rafter and P. Morales, “Protective Effects of Organosulfur Compounds towards N-nitrosamines-induced DNA Damage in the Single-Cell Gel Electrophoresis (SCGE/HepG2 Assay,” Food and Chemical Toxicology, Vol. 45, No. 9, 2007, pp. 1662- 1669.
|
|
[50]
|
Y. Weinrauch and A. Zychlinsky, “The Induction of Apoptosis by Bacterial Pathogens,” Annual Review of Microbiology, Vol. 53, No. 1, 1999, pp. 155-187.
|
|
[51]
|
S. M. DiBartolomeis and J. P. Moné, “Apoptosis: A Four-Week Laboratory Investigation for Advanced Molecular and Cellular Biology Students,” Cell Biology and Education, Vol. 2, No. 4, 2003, pp. 275-295.
|
|
[52]
|
F. H. Igney and P. H. Krammer, “Death and Anti-Death: Tumor Resistance to Apoptosis,” Nature Reviews Cancer, Vol. 2, No. 4, 2002, pp. 277-288.
|
|
[53]
|
C. G. Tepper, M. F. Seldin and M. Mudryi, “Fas- Mediated Apoptosis of Proliferating, Transiently Growth- Arrested, and Senescent Normal Human Fibroblasts,” Experimental Cell Research, Vol. 260, No. 1, 2000, pp. 9-19.
|
|
[54]
|
G. M. Cohen, “Caspases: The Executioners of Apoptosis,” Journal of Biological Chemistry, Vol. 326, 1997, pp. 1-16.
|
|
[55]
|
S. H. Oh and B. H. Lee, “Induction of Apoptosis in Human Hepatoblastoma Cells by Tetrandrine via Caspase- Dependent Bid Cleavage and Cytochrome c Release,” Biochemistry & Pharmacology, Vol., 66, No. 5, 2003, pp. 725-731.
|
|
[56]
|
C. M. Wolf and A. Eastman, “The Temporal Relationship between Protein Phosphatase, Mitochondrial Cytochrome c Release, and Caspase Activation in Apoptosis,” Experimental Cell Research, Vol. 247, No. 2, 1999, pp. 505-513.
|
|
[57]
|
S. Wesselborg, I. H. Engels, E. Rossmann, M. Los and K. Schulze-Osthoff, “Anticancer Drugs Induce Caspase-8/ FLICE Activation and Apoptosis in the Absence of CD95 Receptor/Ligand Interaction,” Blood, Vol. 93, No. 9, 1999, pp. 3053-3063.
|